🇺🇸 FDA
Patent

US 6623721

Bifunctional chelating compounds containing hydroxamic acid residues

expired A61PA61P35/00

Quick answer

US patent 6623721 (Bifunctional chelating compounds containing hydroxamic acid residues) held by Draximage Limited expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Draximage Limited
Grant date
Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00